Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-08-08

Clinical Trial Update: FuRST 2.0 Cognitive Pre-Testing

View source ↗

Summary

The FuRST 2.0 cognitive pre-testing trial for Huntington's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: CHDI Foundation, Inc. | Conditions: Huntington's Disease | Status: COMPLETED